Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD

被引:0
作者
Xiaozhen Li
Tie-Qiang Li
Niels Andreasen
Maria Kristoffersen Wiberg
Eric Westman
Lars-Olof Wahlund
机构
[1] Care Sciences and Society,Department of Neurobiology
[2] Karolinska Institutet,Department of Medical Physics
[3] Karolinska Huddinge,Department of Clinical Science
[4] Karolinska Institutet,undefined
[5] Alzheimer Disease Research Center,undefined
[6] Karolinska Institutet,undefined
[7] Intervention and Technology,undefined
[8] Karolinska Institute,undefined
来源
Scientific Reports | / 3卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The default mode network (DMN) is particularly relevant to Alzheimer's disease (AD) since its structures are vulnerable to deposition of amyloid. Decreased levels of β-amyloid1-42 (Aβ42) and increased total tau protein (T-tau) and tau phosphorylated at position threonine 181 (P-tau181p) in cerebrospinal fluid (CSF) have been established as valid biomarkers for the diagnosis and prognosis of AD. However, the relationship between CSF biomarkers and change in the DMN is still unknown. In this study we investigated the correlation between the functional connectivity within the DMN and the ratio of Aβ42/P-tau181p in the CSF. We found that the ratio of Aβ42/P-tau181p was moderately positively correlated with the functional connectivity within the DMN in the left precuneus/cuneus. This finding implicates that the brain functional connectivity within DMN is affected by pathological changes at early stage in AD. This may provide a better understanding of AD pathology progression and improve AD diagnosis.
引用
收藏
相关论文
共 63 条
  • [1] Blennow K(2006)Alzheimer's disease Lancet 368 387-403
  • [2] De Leon MJ(2001)Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment and Early-Stage Alzheimer's Disease J Mol Neurosci 17 101-118
  • [3] Zetterberg H(2009)Synaptic degeneration in Alzheimer's disease Acta Neuropathol 118 167-79
  • [4] Morris JC(2009)Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain Arch Neurol 66 382-9
  • [5] Price JL(2012)Le The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease Mol Diagn Ther 16 135-141
  • [6] Arendt T(1993)Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme-Linked Immunosorbent Assay J Neurochem 61 1828-1834
  • [7] Tapiola T(2000)Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization Neurosci Lett 285 49-52
  • [8] Engelborghs S(2001)Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice Arch Neurol 58 373-9
  • [9] Bastard N(2012)Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort Neurology 78 47-54
  • [10] Vandermeeren M(2006)Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample Neurobiol Aging 27 1202-11